drugset / Trial / NCT00980278

Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation

NCT00980278 ↗

Phase 1/2 Completed 26 enrolled University of Michigan
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research is to determine if one's own bone marrow tissue can help regenerate (grow) bone in the area of the jaw where an implant will be placed. The name of the process is called Bone Repair Cell (BRC) Therapy. A sample of bone marrow tissue will be collected and sent to a laboratory where it will be processed to form more cells. These new cells will then be transplanted in the regenerative site or sinus floor augmentation site. The researchers are testing to see if these cells (BRC) will help form bone indicating. The research will also determine if the implant will be more stable in the area with new bone growth.

Timeline

Start
2010-03
Primary completion
2013-07
Completion
2013-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aastrom BRCs Cell therapy 10 ml —

Indications